A Retrospective Analysis and Comparison of the STAM and STAMCO Classification and EAONO/JOS Cholesteatoma Staging System in Predicting Surgical Treatment Outcomes of Middle Ear Cholesteatoma.
Hfe van der Toom, M P van der Schroeff, Jmh Janssen, A M Westzaan, R J Pauw
Author Information
Hfe van der Toom: Erasmus Medical Center, Rotterdam, The Netherlands.
OBJECTIVE: To evaluate and compare the STAM classification, STAMCO classification and the EAONO/JOS staging system as predictors for cholesteatoma recidivism and postoperative hearing, using a large patient cohort in our tertiary referral center. METHOD: Two hundred thirty-one patients who underwent surgery for primary cholesteatoma between 2003 and December 2012 were included and retrospectively classified and staged according to the STAM classification, STAMCO classification, and EAONO/JOS staging system. Data on cholesteatoma recidivism rates and postoperative hearing were collected. The predictive value of the three instruments for recurrent and residual cholesteatoma was compared by using receiver operating characteristic curves. RESULTS: For predicting recurrent cholesteatoma, the STAMCO classification was significantly superior compared to the other two instruments. For predicting residual cholesteatoma, the STAMCO classification was superior to the EANO/JOS Staging system. The postoperative hearing shows a significant increase in ABG with increasing extension of cholesteatoma in the CWU group and a significant decrease in AC threshold level with increasing stage and a significant increase in AC with increasing ossicular chain status in the CWD group. CONCLUSION: Based on our study, the STAMCO classification represents the best available predictor for recurrent cholesteatoma and holds most promise for predicting residual cholesteatoma. Extension of cholesteatoma seems to be linked to postoperative hearing and thus the classifications and staging systems may be able to predict postoperative hearing. More studies are needed to assess the validation of these classifications.
References
Yung M, Tono T, Olszewska E, et al. EAONO/JOS Joint Consensus Statements on the Definitions, Classification and Staging of Middle Ear Cholesteatoma. J Int Adv Otol 2017; 13:1–8.
Merkus P, Ten Tije FA, Stam M, Tan FML, Pauw RJ. Implementation of the “EAONO/JOS Definitions and Classification of Middle Ear Cholesteatoma”—from STAM to STAMCO. J Int Adv Otol 2017; 13:272–275.
DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics 1988; 44:837–845.
Tomlin J, Chang D, McCutcheon B, Harris J. Surgical technique and recurrence in cholesteatoma: A meta-analysis. Audiol Neurootol 2013; 18:135–142.
Rutkowska J, Ozgirgin N, Olszewska E. Cholesteatoma definition and classification: A literature review. J Int Adv Otol 2017; 13:266–271.
Saleh HA, Mills RP. Classification and staging of cholesteatoma. Clin Otolaryngol Allied Sci 1999; 24:355–359.
Telmesani LSH, Bahrani N. Proposed clinical classification of cholesteatoma. Egyptian J Ear Nose Throat Allied Sciens 2009; 10:50–53.
Belal ARM, Mehana A, Belal Y. A new staging system for tympanomastoid cholesteatoma. Adv Otol 2012; 8:63–68.
Persaud R, Hajioff D, Trinidade A, et al. Evidence-based review of aetiopathogenic theories of congenital and acquired cholesteatoma. J Laryngol Otol 2007; 121:1013–1019.
Lau T, Tos M. Treatment of sinus cholesteatoma. Long-term results and recurrence rate. Arch Otolaryngol Head Neck Surg 1988; 114:1428–1434.
Lau T, Tos M. Tensa retraction cholesteatoma: Treatment and long-term results. J Laryngol Otol 1989; 103:149–157.
Razek AA, Ghonim MR, Ashraf B. Computed tomography staging of middle ear cholesteatoma. Pol J Radiol 2015; 80:328–333.
Linder TE, Shah S, Martha AS, Roosli C, Emmett SD. Introducing the “ChOLE” classification and its comparison to the EAONO/JOS consensus classification for cholesteatoma staging. Otol Neurotol 2019; 40:63–72.
James AL, Tono T, Cohen MS, et al. International Collaborative Assessment of the Validity of the EAONO-JOS Cholesteatoma Staging System. Otol Neurotol 2019; 40:630–637.
Roger G, Denoyelle F, Chauvin P, Schlegel-Stuhl N, Garabedian EN. Predictive risk factors of residual cholesteatoma in children: A study of 256 cases. Am J Otol 1997; 18:550–558.
Britze A, Moller ML, Ovesen T. Incidence, 10-year recidivism rate and prognostic factors for cholesteatoma. J Laryngol Otol 2017; 131:319–328.
Stangerup SE, Drozdziewicz D, Tos M, Hougaard-Jensen A. Recurrence of attic cholesteatoma: Different methods of estimating recurrence rates. Otolaryngol Head Neck Surg 2000; 123:283–287.
Mor N, Finkel DA, Hanson MB, Rosenfeld RM. Middle ear cholesteatoma treated with a mastoidectomy: A systematic review of the measures used. Otolaryngol Head Neck Surg 2014; 151:923–929.
